✦ LIBER ✦

A.2 The preclinical profile of rotigotine (Neupro®), a novel non-ergolinic dopamine agonist for the transdermal treatment of Parkinson's Disease

✍ Scribed by P. Jenner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A.3 Rotigotine (Neupro®), a new non-ergo

✍ N. Giladi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Transdermal rotigotine: a new non-ergot

✍ Naidu, Y; Chaudhuri, K Ray 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 213 KB

Transdermal Rotigotine: A Clinically Inn

✍ Dr. Jack J. Chen; Dr. David M. Swope; Dr. Khashayar Dashtipour; Dr. Kelly E. Lyo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Pramipexole — a new dopamine agonist for

✍ James P Bennett Jr.; Montford F Piercey 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 121 KB

The in vitro receptor profile of rotigot

✍ Dieter Scheller; Christoph Ullmer; Reinhard Berkels; Mirella Gwarek; Hermann Lüb 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 393 KB

Efficacy, safety, and tolerance of the n

✍ Pinter, M M; Pogarell, O; Oertel, W H 📂 Article 📅 1999 🏛 BMJ Publishing Group 🌐 English ⚖ 195 KB